Catalyst
Slingshot members are tracking this event:
Voclosporin Achieves Primary and All Pre-specified Secondary Endpoints in its Phase IIb AURA-LV Study for Lupus Nephritis (LN)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AUPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 29, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Aura-lv, Lupus Nephritis, Secondary Endpoints
